Meeting
Abstract Number: 53
SHM Converge 2024
Background: Clinicians face substantial challenges in limiting life-prolonging interventions (e.g., ICU admission, life-sustaining treatments, invasive procedures) near the end of life, even when they judge these interventions to be non-beneficial [1-3]. The objective of our study was to empirically derive a descriptive framework of decision-making approaches used by clinicians to limit (i.e., withhold or withdraw) […]
Abstract Number: 101
SHM Converge 2024
Background: Patients with sickle cell disease (SCD) experience painful and life threatening vaso-occlusive episodes (VOE) that cause frequent hospitalizations, account for >80% of their >$1 million lifetime healthcare costs, and can be fatal. Yet, there is a dearth of evidence addressing inpatient VOE care leading to a stark absence of evidence-informed guidelines. As a first […]